Annual Drug Patent Expirations for GELNIQUE+3%25
Gelnique 3% is a drug marketed by Allergan and is included in one NDA. There is one patent protecting this drug.
Drug patent litigation for GELNIQUE 3%.
This drug has fifty-two patent family members in twenty countries.
The generic ingredient in GELNIQUE 3% is oxybutynin. Additional details are available on the oxybutynin profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com